About Genentech Access
Genentech Access is a Healthcare company. It develops and distributes medicines for cancer, eye diseases, and joint conditions. It operates on a B2B and D2C model. Genentech Access offers products and services including ACTEMRA, ALECENSA, Avastin, LUCENTIS, and OCREVUS. Its focus areas include Biotechnology, Pharmaceuticals, Ophthalmology Treatments and Oncology Drugs. Its legal entity is Genentech, Inc.
Company details
Genentech is a biotechnology company that researches, develops, and manufactures pharmaceutical products for diseases in oncology, ophthalmology, and rheumatology. Based in South San Francisco, California, USA, it provides patient access programs, clinical trials, and support services to help individuals obtain treatments. The company collaborates with healthcare professionals and institutions to ensure medicine availability and assists with benefits investigations and appeals.
Products & Services of Genentech Access
Genentech Access offers a comprehensive portfolio of products and services, including ACTEMRA, ALECENSA, Avastin, LUCENTIS, and OCREVUS.
Treatment for rheumatoid arthritis and related conditions
Targets specific lung cancer mutations
Used for various cancer treatments
Injection for eye diseases like macular degeneration
Therapy for multiple sclerosis and related disorders
Apps and channels of Genentech Access
its YouTube channel Roche has 20.8K subscribers and 30 videos.
Videos from Genentech Access
The most watched videos on Genentech Access's YouTube channel, Roche (20.8K subscribers). Click a video to play it here.
More on Roche.
Web traffic of Genentech Access
Websites that share an audience with Genentech Access (genentech-access.com).
Websites whose visitors overlap most with Genentech Access. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| trialcard.com | 87% | 31.4K | #847,120 | View details | |
| smiths-medical.com | 48% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genentech Access
Complete news archive for Genentech Access
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genentech Access
Genentech is a biotechnology company that researches, develops, and manufactures pharmaceutical products for diseases in oncology, ophthalmology, and rheumatology. Based in South San Francisco, California, USA, it provides patient access programs, clinical trials, and support services to help individuals obtain treatments. The company collaborates with healthcare professionals and institutions to ensure medicine availability and assists with benefits investigations and appeals.
Genentech Access offers ACTEMRA, ALECENSA, Avastin, LUCENTIS, and OCREVUS.
Genentech Access operates through Genentech, Inc..